-
Dual targeting of BCMA and GPRC5D with the trispecific antibody ramantamig addresses antigenic heterogeneity in myeloma
O'Neill, C., Broekmans, M. E. C., Korst, C. L. B. M., Krevvata, M., Dal Collo, G., Groen, R. W., Li, B., Baglio, S. R., Philippar, U., Pillarisetti, K., Zweegman, S., Vishwamitra, D., Mutis, T. & van de Donk, N. W. C. J., Oct 2026, In: HemaSphere. 10, 10, p. e70487 e70487.Research output: Contribution to Journal › Article › Academic › peer-review
-
Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma
Raoof, R., Dal Collo, G., Simon-Molas, H., Tzortzi, P., Kulaj, K., Demirez, E. N., Massaro, C., Poels, R., Korst, C. L. B. M., O'Neill, C. A., Bruins, W. S. C., Broekmans, M. E. C., Behradkia, P., Krevvata, M., Zweegman, S., Kater, A. P., Baglio, S. R., Mutis, T. & van de Donk, N. W. C. J., Apr 2026, In: HemaSphere. 10, 4, p. e70358 e70358.Research output: Contribution to Journal › Article › Academic › peer-review
-
Novel immunotherapeutic strategies for multiple myeloma: preclinical and clinical advances
Korst, C. L. B. M., 2026, 232 p.Research output: PhD Thesis › PhD-Thesis - Research and graduation internal
- All publications
